Dr. James Beach brings over eighteen years of experience in imaging systems to direct CytoViva’s hyperspectral systems development program.  Dr. Beach, who joined CytoViva in 2008, led the initial development and deployment of CytoViva’s first hyperspectral imaging product offering.  As director of technology development, Dr. Beach leads the effort to create new imaging and analysis capabilities for the CytoViva product line.

​

In 2000, Dr. Beach co-founded an ophthalmic imaging company located in Reykjavik, Iceland, which markets a retinal oxygen monitoring camera system based on his original work at the University of Virginia.  Over the past decade, he has been involved in the miniaturization of hyperspectral detector systems under NASA-sponsored research programs at the Stennis Space Center, and has contributed to NIH-funded eye research as an adjunct research professor at the Louisiana State University Eye Center in New Orleans, LA.  Dr. Beach received a Space Foundation Hall of Fame award in 2005 for his contributions to portable hyperspectral imaging systems.

​

At CytoViva, Dr. Beach is actively involved in extending the range of applications for hyperspectral microscopy, including both visible and near infrared spectral imaging, three-dimensional volume imaging, and spectral analysis methods for nanoparticle characterization.

​

Dr. Beach earned his bachelor of science degree in electrical engineering in 1971 and master of science degree in bioengineering in 1976, both from the University of Michigan.  He earned his doctoral degree in biomedical engineering from the University of Virginia in 1983.